NetworkNewsBreaks – BriaCell Therapeutics Corp.
Post# of 69
BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, this morning announced that it will be presenting data from biomarker analyses of its clinical trials for advanced breast cancer at the Fourth International Cancer Immunotherapy Conference, as well as at The MicroCap Conference. Both events will take place in New York City. The first presentation, at the Fourth International Cancer Immunotherapy Conference, will take place on Sunday, September 30 at 11:45 am. The second, at The MicroCap Conference, will take place on Monday, October 1 at 4:30 pm. Per the update, Briacell President and CEO Dr. Williams will be available to answer questions following the presentation at The MicroCap Conference.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer